Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

INTRODUCTION: Many immunomodulators have been studied in clinical trials for the treatment of coronavirus disease 2019 (COVID-19). However, data identifying the most effective and safest treatment are lacking. We conducted a systematic review and network meta-analysis to rank immunomodulators in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngamprasertchai, Thundon, Kajeekul, Rattagan, Sivakorn, Chaisith, Ruenroegnboon, Narisa, Luvira, Viravarn, Siripoon, Tanaya, Luangasanatip, Nantasit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579415/
https://www.ncbi.nlm.nih.gov/pubmed/34757578
http://dx.doi.org/10.1007/s40121-021-00545-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579415/
https://www.ncbi.nlm.nih.gov/pubmed/34757578
http://dx.doi.org/10.1007/s40121-021-00545-0

Ejemplares similares